GleamWall
中文EN

POCI PRECISION OPTICS CORPORATION, INC.

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 867840 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY53.0%
TTM net income YoY59.6%
TTM EPS YoY69.4%
Revenue 3-yr CAGR17.6%
Net income 3-yr CAGR—

Margins

Gross margin19.2%
Operating margin-7.4%
Net margin-7.5%
FCF margin—
EBITDA margin-6.5%

Returns

ROE-15.9%
ROA-9.3%
ROIC (approx.)-16.3%
Asset turnover1.25x

Leverage & solvency

Liabilities / assets34.0%
Debt / equity0.06x
Current ratio2.46x
Interest coverage-17.82x

Cash quality & payout

Operating cash flow / net income0.93x
Accruals ratio-0.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-09-302026Q4*2026-06-302026Q32026-03-312026Q22025-12-312026Q12025-09-302025Q4*2025-06-302025Q32025-03-312025Q22024-12-31
Income statement
Revenue$8.15M$8.77M$8.71M$7.37M$6.68M$6.18M$4.19M$4.53M
Cost of revenue$6.31M$6.55M$6.65M$7.16M$5.73M$5.38M$3.77M$3.46M
Gross profit$1.84M$2.22M$2.06M$204,660$946,358$799,186$417,975$1.07M
R&D expense$306,215$204,423$267,319$249,574$311,840$228,315$211,242$317,747
SG&A expense$2.05M$2.13M$1.85M$1.70M$2.23M$1.93M$2.25M$1.66M
Operating income-$518,310-$106,562-$64,462-$1.74M-$1.60M-$1.36M-$2.04M-$910,021
Interest expense$30,121$32,776$35,116$38,462$41,775$44,577$58,476$59,660
Pretax income—-$107,534-$99,578——-$1.40M-$2.10M—
Income tax—-$3,747$8,705——$1,936$0—
Net income-$474,854-$103,787-$108,283-$1.78M-$1.64M-$1.40M-$2.10M-$969,681
EBITDA-$453,039-$42,233$11,140-$1.67M-$1.53M-$1.30M-$1.98M-$860,825
EPS (basic)-0.04—-0.01-0.23-0.21—-0.30-0.15
EPS (diluted)-0.04—-0.01-0.23-0.21—-0.30-0.15
Weighted avg. shares (diluted)10.97M—7.79M7.71M7.71M—6.92M6.35M
Balance sheet
Cash & equivalents$8.97M$9.84M$10.68M$881,486$1.39M$1.77M$2.55M$212,441
Receivables$5.37M$5.94M$6.58M$4.87M$4.19M$4.34M$3.43M$3.51M
Inventory$3.52M$3.83M$3.70M$4.26M$3.88M$3.56M$3.67M$3.85M
Current assets$18.44M$20.11M$21.41M$10.42M$9.86M$10.06M$9.97M$7.84M
PP&E, net$912,997$887,713$868,713$989,347$960,878$533,792$533,869$450,257
Goodwill$8.82M$8.82M$8.82M$8.82M$8.82M$8.82M$8.82M$8.82M
Intangibles$206,597$212,889$215,507$219,967$226,259$232,493$236,256$292,474
Total assets$30.62M$32.34M$33.69M$22.90M$22.38M$19.79M$19.62M$17.51M
Current liabilities$7.50M$8.83M$10.19M$9.95M$7.62M$6.15M$5.01M$6.41M
Short-term debt$577,898$577,898$577,898$577,898$577,898$577,898$576,405$427,763
Long-term debt$562,023$711,305$855,780$1.00M$1.14M$1.29M$1.44M$1.61M
Total debt$1.14M$1.29M$1.43M$1.58M$1.72M$1.87M$2.01M$2.04M
Total liabilities$10.42M$11.99M$13.58M$13.57M$11.46M$7.53M$6.44M$8.03M
Shareholders' equity$20.20M$20.35M$20.11M$9.33M$10.92M$12.26M$13.18M$9.48M
Net debt-$7.83M-$8.55M-$9.25M$696,667$330,523$93,368-$536,123$1.83M
Shares outstanding10.99M10.97M10.93M7.72M7.71M7.71M7.67M6.36M
Cash flow statement
Operating cash flow-$672,145-$649,109-$723,258-$256,079$78,227-$569,235-$1.87M-$786,809
Capital expenditure$84,263———$304,731$46,224$126,815$29,821
Free cash flow-$756,408———-$226,504-$615,459-$2.00M-$816,630
Investing cash flow-$48,025-$80,711$49,492-$96,342-$301,789-$83,636-$89,752-$31,986
Financing cash flow-$154,083-$109,084$10.47M-$158,198-$158,068-$121,267$4.30M$395,664
Depreciation & amortization$65,271$64,329$75,602$74,165$65,181$52,595$62,358$49,196
Stock-based compensation$235,528$397,193$247,528$162,081$301,639$439,874$562,964$308,206

Free plan shows the latest 8 periods; Pro shows all 65 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.